Related references
Note: Only part of the references are listed.Efficacy and Tolerability of a 2-Year Rituximab Maintenance Therapy in Patients with Advanced Follicular Lymphoma after Induction of Response with Rituximab-Containing First Line-Regimens (HUSOM Study)
Tamas Schneider et al.
PATHOLOGY & ONCOLOGY RESEARCH (2018)
Rituximab maintenance therapy of follicular lymphoma in clinical practice
Ulrich Duehrsen et al.
CANCER MEDICINE (2018)
Rituximab Maintenance Therapy After First-Line induction Chemoimmunotherapy for Follicular Lymphoma
Talal Hilal et al.
JAMA ONCOLOGY (2018)
Rituximab maintenance therapy for patients with diffuse large B-cell lymphoma: A meta-analysis
Xuan Zhou et al.
PLOS ONE (2017)
Diffuse large B-cell lymphoma: can genomics improve treatment options for a curable cancer?
Amit Dipak Amin et al.
COLD SPRING HARBOR MOLECULAR CASE STUDIES (2017)
Autologous stem cell transplantation for relapsed/refractory diffuse large B-cell lymphoma: efficacy in the rituximab era and comparison to first allogeneic transplants. A report from the EBMT Lymphoma Working Party
S. P. Robinson et al.
BONE MARROW TRANSPLANTATION (2016)
Incidence of intensive care unit admission, outcome and post intensive care survival in patients with diffuse large B-cell lymphoma
Philipp Wohlfarth et al.
LEUKEMIA & LYMPHOMA (2016)
Life expectancy of young adults with follicular lymphoma
A. Conconi et al.
ANNALS OF ONCOLOGY (2015)
Rituximab maintenance improves survival in male patients with diffuse large B-cell lymphoma. Results of the HD2002 prospective multicentre randomized phase III trial
Mathias Witzens-Harig et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
SEOM clinical guidelines for the treatment of follicular non-Hodgkin's lymphoma
M. Provencio Pulla et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2015)
Efficacy and feasibility of autologous stem cell transplantation in patients with diffuse large B-cell lymphoma with secondary central nervous system involvement
Min-Young Lee et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2015)
Comparing the Cost-Effectiveness of Rituximab Maintenance and Radioimmunotherapy Consolidation versus Observation Folio First-Line Therapy in Patients with Follicular Lymphoma
Qiushi Chen et al.
VALUE IN HEALTH (2015)
Autologous hematopoietic stem cell transplantation in elderly patients (≥70 years) with non-Hodgkin's lymphoma: A French Society of Bone Marrow Transplantation and Cellular Therapy retrospective study
E. Hermet et al.
JOURNAL OF GERIATRIC ONCOLOGY (2015)
Real world costs and cost-effectiveness of Rituximab for diffuse large B-cell lymphoma patients: a population-based analysis
Sara Khor et al.
BMC CANCER (2014)
Comparative Effectiveness and Cost of Adding Rituximab to First-Line Chemotherapy for Elderly Patients Diagnosed With Diffuse Large B-Cell Lymphoma
Robert I. Griffiths et al.
CANCER (2012)
Autologous Stem Cell Transplantation in Follicular Lymphoma: a Systematic Review and Meta-analysis
Murtadha Al Khabori et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
Cost-effectiveness of rituximab in follicular lymphoma
Karissa M. Johnston et al.
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2012)
Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Jonathan W. Friedberg
HEMATOLOGY-AMERICAN SOCIETY HEMATOLOGY EDUCATION PROGRAM (2011)
Cost-effectiveness of pegfilgrastim versus 6-day filgrastim primary prophylaxis in patients with non-Hodgkin's lymphoma receiving CHOP-21 in United States
Gary Lyman et al.
CURRENT MEDICAL RESEARCH AND OPINION (2009)
Economic Burden of Follicular Non-Hodgkin's Lymphoma
Talia Foster et al.
PHARMACOECONOMICS (2009)
Medical costs associated with non-Hodgkin's lymphoma in the United States during the first two years of treatment
Lucie Kutikova et al.
LEUKEMIA & LYMPHOMA (2006)
The clinical course of follicular lymphoma
AZS Rohatiner et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2005)
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
B Coiffier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)